STSimone Tonetto

Simone Tonetto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simone Tonetto has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Gjedde

    Department of Neuroscience, University of Copenhagen, Panum Institute, Copenhagen, Denmark

    1 shared publication
  • Anders Fink-Jensen

    Psychiatric Centre Copenhagen, Mental Health Services in the Capital Region of Copenhagen, Copenhagen, Denmark

    1 shared publication
  • Anne K. Sigvard

    Center for Neuropsychiatric Schizophrenia Research and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Centre Glostrup, Copenhagen University Hospital, Glostrup, Denmark

    1 shared publication
  • Annika Billefeld Bornebusch

    Laboratory of Neuropsychiatry, Psychiatric Center Copenhagen, Rigshospitalet, Mental Health Services-Capital Region of Denmark, Copenhagen, Denmark

    1 shared publication
  • Birte Yding Glenthoej

    Center for Neuropsychiatric Schizophrenia Research, CNSR, and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Center Glostrup, Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Glostrup, Denmark

    1 shared publication
  • Bjørn Hylsebeck Ebdrup

    Center for Neuropsychiatric Schizophrenia Research, CNSR, and Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS, Mental Health Center Glostrup, Glostrup, Copenhagen University Hospital - Mental Health Services CPH, Glostrup, Denmark

    1 shared publication

Latest Publications

  • Glycocalyx shedding patterns identifies antipsychotic-naïve patients with first-episode psychosis

    by Helle G. Andersen, Brian DellaValle, Hjalte Bøgehave, Phillip Bredahl Mogensen, Margaret K. Hahn, Christoffer K. Goth, Mikkel E. Sørensen, Anne K. Sigvard, Karen Tangmose, Kirsten B. Bojesen, et al.


  • Open Access

    Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice

    by Annika Billefeld Bornebusch, Graeme F. Mason, Simone Tonetto, Jakob Damsgaard, Albert Gjedde, Anders Fink-Jensen, Morgane Thomsen

    Rationale After alcohol ingestion, the brain partly switches from consumption of glucose to consumption of the alcohol metabolite acetate. In heavy drinkers, the switch persists after abrupt abstinence, leading to the hypothesis that the resting brain may be “starved” when acetate levels suddenly drop during abstinence, despite normal blood glucose, contributing to withdrawal symptoms. We hypothesized that ketone bodies, like acetate, could act as alternative fuels in the brain and alleviate withdrawal symptoms. Objectives We previously reported that a ketogenic diet during alcohol exposure reduced acute withdrawal symptoms in rats. Here, our goals were to test whether (1) we could reproduce our findings, in mice and with longer alcohol exposure; (2) ketone bodies alone are sufficient to reduce withdrawal symptoms (clarifying mechanism); (3) introduction of ketogenic diets at abstinence (a clinically more practical implementation) would also be effective. Methods Male C57BL/6NTac mice had intermittent alcohol exposure for 3 weeks using liquid diet. Somatic alcohol withdrawal symptoms were measured as handling-induced convulsions; anxiety-like behavior was measured using the light-dark transition test. We tested a ketogenic diet, and a ketone monoester supplement with a regular carbohydrate-containing diet. Results The regular diet with ketone monoester was sufficient to reduce handling-induced convulsions and anxiety-like behaviors in early withdrawal. Only the ketone monoester reduced handling-induced convulsions when given during abstinence, consistent with faster elevation of blood ketones, relative to ketogenic diet. Conclusions These findings support the potential utility of therapeutic ketosis as an adjunctive treatment in early detoxification in alcohol-dependent patients seeking to become abstinent. Trial registration clinicaltrials.gov NCT03878225, NCT03255031